SCCR21: Proposal for the consideration of the African Group on a Decision on SCCR

The following proposal for a road map for the SCCR’s consideration of limitations and exceptions was submitted by the African Group on Tuesday, 9 November 2010.

Proposal for the consideration of the African Group on a Decision on SCCR

(Limitations and exceptions)

Bearing in mind

SCCR 21: General statement of Group B (covering broadcasting, AV protection and limitations and exceptions)

The following general statement was delivered by France, on behalf of Group B, on the first day (8 November 2010) of SCCR 21.

SCCR 21
Group B opening statement

I thank you M. Chair,

Group B is glad to welcome you back in Geneva for this 21st session of the Standing Committee on Copyright and Related Rights, which we hope will be a productive one.

Continue Reading

SCCR 21: Initial impressions from day 1

The 21st session of the WIPO Standing Committee on Copyright and Related Rights (SCCR) commenced its work at 10:33 AM on Monday, 8 November 2010.

This unusually quick start is perhaps indicative of Member States’ commitment to examine the three substantive agenda items up for consideration during this five day negotiation; these three issues include: 1) protection of broadcasting organizations, 2) protection of audiovisual performances and 3) limitations and exceptions.

Continue Reading

1

ACTA: USTR’s talking points to WTO Council for TRIPS

The following statement is the oral intervention made by USTR at the WTO Council for TRIPS (October 2010) regarding ACTA.

Talking Points of the United States for TRIPS Council Meeting of October 26, 2010
Agenda Item P
ACTA

We would like to thank other delegations for their interest in the Anti-Counterfeiting Trade Agreement (ACTA).
Delegations will recall that the United States and other delegations have been interested in discussing the issue of IP enforcement at this Council for many years and so we’re pleased to have another discussion today.

Continue Reading

Uncategorized

Statement of the United States to WTO TRIPS Council on the Paragraph 6 System

The following statement was delivered by USTR at the WTO Council for TRIPS Annual Review of the Paragraph 6 System on Wednesday, 27 October 2010.

Statement of the United States
Agenda item F, Annual Review of the Paragraph 6 System
Topic 5

Mr. Chairman

We are pleased to be here today to participate in the annual review on the implementation of paragraph 6 of the Doha Declaration.

Continue Reading

Uncategorized

Remarks by UNAIDS Secretariat and on behalf of UNDP: Capacity building on the Paragraph 6 System and related TRIPS flexibilities

The following statement was delivered on Wednesday, 27 October 2010 by the UNAIDS Secretariat and on behalf of UNDP during the Annual Review of Paragraph 6.

World Trade Organization
Council for TRIPS – Regular Session
Annual Review of Paragraph 6
Doha Declaration on the TRIPS Agreement and Public Health
Agenda item 4 – Capacity building on the Paragraph 6 System and related TRIPS flexibilities
Remarks by UNAIDS Secretariat and on behalf of UNDP
27 October 2010

Mr Chair, Distinguished Delegates

Continue Reading

Uncategorized

Paragraph 6 system: Brazilian intervention at the WTO TRIPS Council

On Wednesday, 27 October 2010, Brazil delivered the following intervention during the annual review of the Paragraph 6 system at the WTO TRIPS Council. The Brazilian intervention followed Canada’s detailed explanation of her use of the Paragraph 6 system in the Apotex/Rwanda case. The Brazilian intervention voiced concern over the future prospects of access to competitively priced second and third line ARVs raising questions as to whether the Paragraph 6 system would be economically viable for generic producers.

Continue Reading

Uncategorized

Michèle Rivasi asks question about ACTA and Access to Medicine

225px-michel-rivasi.jpg Michèle Rivasi, a Member of the European Parliament, representing South East France for The Greens, has asked the European Commission: “Given the possible impacts of the inclusion of patents the agreement on access to medicines and on innovation, would the Commission consider accepting the exclusion of patents from the agreement as proposed by a number of ACTA negotiating parties?” The full text of her question follows:

Continue Reading

Uncategorized